Brain Mapping Instruments Market

By Product;

Computed Axial Tomography (CAT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnetoencephalography, Functional Near-Infrared Spectroscopy (fNIRS), Functional Magnetic Resonance Imaging (fMRI) and Others

By Procedure;

Devices For Invasive Procedures and Devices For Non-invasive Procedures

By End User;

Hospitals, Diagnostic Centers and Other End Users

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn550267855 Published Date: June, 2025 Updated Date: August, 2025

Brain Mapping Instruments Market Overview

Brain Mapping Instruments Market (USD Million)

Brain Mapping Instruments Market was valued at USD 2,416.92 million in the year 2024. The size of this market is expected to increase to USD 4,250.77 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.


Brain Mapping Instruments Market

*Market size in USD million

CAGR 8.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.4 %
Market Size (2024)USD 2,416.92 Million
Market Size (2031)USD 4,250.77 Million
Market ConcentrationMedium
Report Pages375
2,416.92
2024
4,250.77
2031

Major Players

  • Medtronic.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Siemens Healthcare Private Limited
  • Advanced Brain Monitoring, Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Brain Mapping Instruments Market

Fragmented - Highly competitive market without dominant players


The Brain Mapping Instruments Market is propelled by robust technological advancements, as more than 60% of development targets high-resolution EEG, MEG, and fNIRS solutions. These advances improve efficacy, enabling precise identification of brain activity patterns. Superior imaging clarity is driving steady growth and increasing demand in neurology and cognitive research.

Integrated Development Boosting Clinical Usability
Nearly 50% of instruments emerge from collaboration and partnerships between industry, research institutions, and surgical teams. These strategies optimize mapping workflows, validate neurofunctional accuracy, and embed systems into treatment planning. Such unity is supporting broad expansion in neurosurgery and brain–computer interface fields.

Strategic Mergers Elevating Production and Reach
Close to 35% of market momentum is tied to merger activity connecting instrument manufacturers with software analytics firms and service providers. These alliances bolster technological capabilities, increase output, and enhance support infrastructure. The consolidation lays the groundwork for scalable expansion of mapping tool access.

AI‑Enabled Analytics Streamlining Interpretive Workflows
With over 50% of labs employing AI-driven dashboards to analyze brain mapping data, clinical workflows have become more efficient. These systems identify signal patterns, alert anomalies, and assist in real-time decision-making. Integrating analytics into instrumentation exemplifies core technological advancements, fueling sustained growth and promising future outlook in brain mapping.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Procedure
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Brain Mapping Instruments Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. AI integration in brain mapping
        2. Early brain disorder diagnosis need
        3. Non-invasive mapping technique adoption
        4. Brain mapping applications diversification
      2. Restraints
        1. New tech resistance
        2. Mapping accuracy technical limitations
        3. Data interpretation reliability concerns
      3. Opportunities
        1. Neurological disorder intervention
        2. Non-medical field research growth
        3. Neuropharmaceutical trial utilization
        4. Advanced software for analysis
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Brain Mapping Instruments Market, By Product, 2021 - 2031 (USD Million)
      1. Computed Axial Tomography (CAT)
      2. Positron Emission Tomography (PET)
      3. Electroencephalography (EEG)
      4. Magnetoencephalography
      5. Functional Near-Infrared Spectroscopy (fNIRS)
      6. Functional Magnetic Resonance Imaging (fMRI)
      7. Others
    2. Brain Mapping Instruments Market, By Procedure, 2021 - 2031 (USD Million)
      1. Devices For Invasive Procedures
      2. Devices For Non-invasive Procedures
    3. Brain Mapping Instruments Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    4. Brain Mapping Instruments Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Medtronic.
      2. General Electric Company
      3. Koninklijke Philips N.V.
      4. Siemens Healthcare Private Limited
      5. Advanced Brain Monitoring, Inc
  7. Analyst Views
  8. Future Outlook of the Market